Spyre Therapeutics Inc (SYRE) Stock Price, Quote, News & History

SYRENASDAQ
$86.94
-1.73-1.95%
Last update: Jun 26, 1:04 PM
Loading...

Key Statistics

Open
$88.44
Close
-
Volume / Avg.
625.17K / 1.33M
Day Range
$86.83 - $89.88
52 Wk Range
14.00 - 102.06
Market Cap
$7.50B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
56
Short Interest
15.66%
Days to Cover
10.83

Recent Spyre Therapeutics Inc News

No news found

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-185.63M
Investing Cash Flow (TTM)
-86.83M
Financing Cash Flow (TTM)
321.15M
Free Cash Flow (TTM)
-185.63M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
48.69M

Analyst Trends and Forecast

3
Mar
9
Apr
2
May
3
Jun
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$7.11B
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
14.95
Earnings Yield % (TTM)
-2.39%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$5.93

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$97.19M
Debt to Equity
-
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$88.44
Close
-
Volume / Avg.
625.17K / 1.33M
Day Range
$86.83 - $89.88
52 Wk Range
14.00 - 102.06
Market Cap
$7.50B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
56
Short Interest
15.66%
Days to Cover
10.83

About

Sector
Health Care
Industry
Biotechnology
Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases. Spyre's pipeline includes exten...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Spyre Therapeutics (SYRE) stock?

A

You can purchase shares of Spyre Therapeutics (NASDAQ:SYRE) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Spyre Therapeutics (SYRE) competitors?

A

There are no as such competitors for Spyre Therapeutics.

Q

What is the forecast, or price target, for Spyre Therapeutics (SYRE) stock?

A

Spyre Therapeutics has a consensus price target of $85.60.

Q

What is the current price for Spyre Therapeutics (SYRE)?

A

The stock price for Spyre Therapeutics (NASDAQ: SYRE) is $86.945 last updated June 26, 2026 at 1:04 PM EDT.

Q

Does Spyre Therapeutics (SYRE) pay a dividend?

A

There are no upcoming dividends for Spyre Therapeutics.

Q

When is Spyre Therapeutics (NASDAQ:SYRE) reporting earnings?

A

Spyre Therapeutics does not have any upcoming earnings scheduled.

Q

Is Spyre Therapeutics (SYRE) going to split?

A

There is no upcoming split for Spyre Therapeutics.

Q

What sector and industry does Spyre Therapeutics (SYRE) operate in?

A

Spyre Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.